At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02179 RECBIO-B
Trading 11-15 15:48:40
7.950
-0.450
-5.36%
High8.390
Low7.900
Vol23.00K
Open8.390
D1 Closing8.400
Amplitude5.83%
Mkt Cap3.84B
Tradable Cap2.51B
Total Shares482.96M
T/O186.08K
T/O Rate0.01%
Tradable Shares316.14M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Jiangsu Recbio Technology to Issue Up to 800 Million Yuan of Shares to Pharmaceutical Company
Institutions along with retail investors who hold considerable shares inJiangsu Recbio Technology Co., Ltd. (HKG:2179) come under pressure; lose 10% of holdings value
Jiangsu Recbio Technology Co Ltd is a China-based company mainly engaged in the research and development of vaccines. The Company has a portfolio of clinical-stage and pre-clinical stage vaccines, and its human papilloma virus (HPV) vaccine pipelines comprise of recombinant HPV 9-valent vaccine REC603, recombinant HPV 9-valent vaccines REC601 and REC602, recombinant HPV quadrivalent vaccine REC604a, and recombinant HPV 9-valent vaccine REC604b. The Company also involves in the development of Covid-19 vaccines. The Company mainly distributes products within domestic market.